Bolt Biotherapeutics Inc logo

Bolt Biotherapeutics Inc

NEW
NAS:BOLT (USA)   Ordinary Shares
$ 0.64 -0.01 (-1.55%) 07:09 PM EST
At Loss
P/B:
0.29
Market Cap:
$ 24.29M
Enterprise V:
$ -30.04M
Volume:
31.34K
Avg Vol (2M):
154.99K
Trade In:
Volume:
31.34K
At Loss
Avg Vol (2M):
154.99K

Business Description

Bolt Biotherapeutics Inc logo
Bolt Biotherapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US0977021049

Share Class Description:

BOLT: Ordinary Shares
Description
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Name Current Vs Industry Vs History
Cash-To-Debt 3.9
Equity-to-Asset 0.69
Debt-to-Equity 0.22
Debt-to-EBITDA -0.26
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.18
Distress
Grey
Safe
Beneish M-Score -2.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.41
9-Day RSI 47.92
14-Day RSI 49.39
6-1 Month Momentum % -41.36
12-1 Month Momentum % -33.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.28
Quick Ratio 4.28
Cash Ratio 4.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.2
Shareholder Yield % 9.94

Financials (Next Earnings Date:2024-11-08 Est.)

BOLT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BOLT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bolt Biotherapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 11.166
EPS (TTM) ($) -1.74
Beta 0.76
Volatility % 61.27
14-Day RSI 49.39
14-Day ATR ($) 0.038389
20-Day SMA ($) 0.64783
12-1 Month Momentum % -33.88
52-Week Range ($) 0.545 - 1.56
Shares Outstanding (Mil) 38.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bolt Biotherapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Bolt Biotherapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Bolt Biotherapeutics Inc Frequently Asked Questions

What is Bolt Biotherapeutics Inc(BOLT)'s stock price today?
The current price of BOLT is $0.64. The 52 week high of BOLT is $1.56 and 52 week low is $0.55.
When is next earnings date of Bolt Biotherapeutics Inc(BOLT)?
The next earnings date of Bolt Biotherapeutics Inc(BOLT) is 2024-11-08 Est..
Does Bolt Biotherapeutics Inc(BOLT) pay dividends? If so, how much?
Bolt Biotherapeutics Inc(BOLT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1